An analysis of iron deficiency anaemia investigations in a district general hospital with particular reference to British Society of Gastroenterology guidelines

Endoscopy ◽  
2005 ◽  
Vol 37 (05) ◽  
Author(s):  
S Dalmia ◽  
K Nagpal ◽  
U Mia ◽  
G Mathew
2013 ◽  
Vol 5 (3) ◽  
pp. 219-223 ◽  
Author(s):  
Susan L Surgenor ◽  
Silvia Kirkham ◽  
Sally D Parry ◽  
Elizabeth J Williams ◽  
Jonathon A Snook

Gut ◽  
2013 ◽  
Vol 62 (Suppl 1) ◽  
pp. A264.2-A265
Author(s):  
B M Shandro ◽  
R Basuroy ◽  
L Gamble ◽  
S Edwards ◽  
S Al-Shamma ◽  
...  

Gut ◽  
2007 ◽  
Vol 56 (9) ◽  
pp. 1319-1319 ◽  
Author(s):  
K. Gregory ◽  
M. Halliday ◽  
C. Averill ◽  
N. Bhala ◽  
C. Tselepis ◽  
...  

Gut ◽  
2021 ◽  
pp. gutjnl-2021-325210
Author(s):  
Jonathon Snook ◽  
Neeraj Bhala ◽  
Ian L P Beales ◽  
David Cannings ◽  
Chris Kightley ◽  
...  

Iron deficiency anaemia (IDA) is a major cause of morbidity and burden of disease worldwide. It can generally be diagnosed by blood testing and remedied by iron replacement therapy (IRT) using the oral or intravenous route. The many causes of iron deficiency include poor dietary intake and malabsorption of dietary iron, as well as a number of significant gastrointestinal (GI) pathologies. Because blood is iron-rich it can result from chronic blood loss, and this is a common mechanism underlying the development of IDA—for example, as a consequence of menstrual or GI blood loss.Approximately a third of men and postmenopausal women presenting with IDA have an underlying pathological abnormality, most commonly in the GI tract. Therefore optimal management of IDA requires IRT in combination with appropriate investigation to establish the underlying cause. Unexplained IDA in all at-risk individuals is an accepted indication for fast-track secondary care referral in the UK because GI malignancies can present in this way, often in the absence of specific symptoms. Bidirectional GI endoscopy is the standard diagnostic approach to examination of the upper and lower GI tract, though radiological scanning is an alternative in some situations for assessing the large bowel. In recurrent or refractory IDA, wireless capsule endoscopy plays an important role in assessment of the small bowel.IDA may present in primary care or across a range of specialties in secondary care, and because of this and the insidious nature of the condition it has not always been optimally managed despite the considerable burden of disease— with investigation sometimes being inappropriate, incorrectly timed or incomplete, and the role of IRT for symptom relief neglected. It is therefore important that contemporary guidelines for the management of IDA are available to all clinicians. This document is a revision of previous British Society of Gastroenterology guidelines, updated in the light of subsequent evidence and developments.


2021 ◽  
Vol 108 (Supplement_6) ◽  
Author(s):  
Y Abdallah ◽  
S Maryosh ◽  
C Caldwell ◽  
Ahmad Zia ◽  
H Fellows

Abstract Aim The British Society of Gastroenterology guidelines recommend Helicobacter pylori (HP) testing in patients with iron deficiency anaemia (IDA). This quality improvement project evaluates the utility of histological examination for HP in IDA patients, the consequent expenditure and whether a more cost-effective alternative exists. Method A retrospective search was conducted of patients within a four-month period who underwent an oesophago-gastroduodenoscopy (OGD) for IDA. Patients with an identifiable cause of IDA, ferritin >40ug/mL and haemoglobin (Hb) >12g/L in women or > 13g/L in men were excluded. The costings of a single tissue biopsy and HP stool testing were sought from our local departments. Results Ninety-nine patients’ results were analysed after exclusions (n = 99/127, 78.0%). All patients had biopsies taken at OGD. On average, three biopsies were obtained per patient. Forty-two patients had no abnormalities visualized on OGD and all ninety-nine patients were HP negative. A single biopsy costs £70; £65 per hematoxylin and eosin based histological examination and £5 per single-use biopsy forceps. Accounting for forty-two patients with macroscopically normal OGDs leads to a total expenditure of £8820. A HP stool test costs £14. Conclusions Guidelines recommend HP testing either non-invasively or at OGD as an alternative strategy, based on weak evidence that HP may cause IDA. HP prevalence is falling; histological examination of biopsies obtained at OGD therefore appears expensive and unnecessary. It is more cost effective to perform a stool test in the case of a normal OGD and commence treatment accordingly with biopsies reserved when otherwise clinically indicated and not solely for HP testing.


Sign in / Sign up

Export Citation Format

Share Document